These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20332697)

  • 1. [A case of metastatic pancreatic cancer with a remarkable response to combination therapy of gemcitabine and adoptive immune cell therapy].
    Imai N; Takeda K; Utsunomiya S; Taga M; Kawata N; Ikeda T; Mizutani Y; Hirose K; Ishikawa T; Yoshida S
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):527-9. PubMed ID: 20332697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive immunotherapy with MUC1-mRNA transfected dendritic cells and cytotoxic lymphocytes plus gemcitabine for unresectable pancreatic cancer.
    Shindo Y; Hazama S; Maeda Y; Matsui H; Iida M; Suzuki N; Yoshimura K; Ueno T; Yoshino S; Sakai K; Suehiro Y; Yamasaki T; Hinoda Y; Oka M
    J Transl Med; 2014 Jun; 12():175. PubMed ID: 24947606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative Adjuvant Therapy for Resectable Pancreatic Cancer With Gemcitabine and Adoptive Immunotherapy.
    Matsui H; Hazama S; Sakamoto K; Shindo Y; Kanekiyo S; Nakashima M; Matsukuma S; Tokuhisa Y; Iida M; Suzuki N; Yoshimura K; Takeda S; Ueno T; Yoshino S; Oka M; Nagano H
    Pancreas; 2017 Sep; 46(8):994-1002. PubMed ID: 28697053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I pilot study of Wilms tumor gene 1 peptide-pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer.
    Mayanagi S; Kitago M; Sakurai T; Matsuda T; Fujita T; Higuchi H; Taguchi J; Takeuchi H; Itano O; Aiura K; Hamamoto Y; Takaishi H; Okamoto M; Sunamura M; Kawakami Y; Kitagawa Y
    Cancer Sci; 2015 Apr; 106(4):397-406. PubMed ID: 25614082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer liver metastasis.
    Ho TTB; Nasti A; Seki A; Komura T; Inui H; Kozaka T; Kitamura Y; Shiba K; Yamashita T; Yamashita T; Mizukoshi E; Kawaguchi K; Wada T; Honda M; Kaneko S; Sakai Y
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33188035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma.
    Ghansah T; Vohra N; Kinney K; Weber A; Kodumudi K; Springett G; Sarnaik AA; Pilon-Thomas S
    Cancer Immunol Immunother; 2013 Jun; 62(6):1083-91. PubMed ID: 23604104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer.
    Hirooka Y; Itoh A; Kawashima H; Hara K; Nonogaki K; Kasugai T; Ohno E; Ishikawa T; Matsubara H; Ishigami M; Katano Y; Ohmiya N; Niwa Y; Yamamoto K; Kaneko T; Nieda M; Yokokawa K; Goto H
    Pancreas; 2009 Apr; 38(3):e69-74. PubMed ID: 19276867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years].
    Yajima T; Furukawa Y; Ishii Y; Hattori Y; Matsumoto N; Yamamoto M; Yamaoka Y; Fujihara M; Fujita M; Kuniki H
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):953-7. PubMed ID: 15222120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of liver metastasis of pancreatic duct carcinoma successfully treated with gemcitabine].
    Tsujie M; Nakamori S; Nakazuru S; Hayashi N; Okami J; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Gan To Kagaku Ryoho; 2003 Feb; 30(2):297-301. PubMed ID: 12610883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival.
    Ogura Y; Mizumoto K; Nagai E; Murakami M; Inadome N; Saimura M; Matsumoto K; Nakamura T; Maemondo M; Nukiwa T; Tanaka M
    Cancer Gene Ther; 2006 May; 13(5):520-9. PubMed ID: 16341142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term survival of a patient with locally advanced unresectable pancreatic cancer treated with gemcitabine after chemoradiation therapy].
    Chohno T; Aoki T; Hyuga S; Watanabe R; Matsumoto T; Takemoto H; Takachi K; Nishioka K; Uemura Y; Kobayashi K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1881-3. PubMed ID: 24393953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of locally advanced pancreatic cancer with superior membrane artery invasion successfully resected after gemcitabine-based chemoradiotherapy].
    Ohmura Y; Takeda Y; Nagano H; Nakamori S; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Kitagawa T; Monden M; Mori M; Doki Y
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2428-9. PubMed ID: 20037445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two cases of pancreatic cancer with multiple liver metastases treated with radical treatment after successful treatment with gemcitabine plus S-1 therapy].
    Sato Y; Tsuchiya Y; Aizawa M; Nomura T; Nashimoto A
    Gan To Kagaku Ryoho; 2014 Sep; 41(9):1151-4. PubMed ID: 25248901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 1 trial of Wilms tumor 1 (WT1) peptide vaccine and gemcitabine combination therapy in patients with advanced pancreatic or biliary tract cancer.
    Kaida M; Morita-Hoshi Y; Soeda A; Wakeda T; Yamaki Y; Kojima Y; Ueno H; Kondo S; Morizane C; Ikeda M; Okusaka T; Takaue Y; Heike Y
    J Immunother; 2011 Jan; 34(1):92-9. PubMed ID: 21150717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.
    Li Y; Sun J; Jiang Z; Zhang L; Liu G
    J Chemother; 2015 Aug; 27(4):227-34. PubMed ID: 25790948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I clinical trial of vaccination with KIF20A-derived peptide in combination with gemcitabine for patients with advanced pancreatic cancer.
    Suzuki N; Hazama S; Ueno T; Matsui H; Shindo Y; Iida M; Yoshimura K; Yoshino S; Takeda K; Oka M
    J Immunother; 2014 Jan; 37(1):36-42. PubMed ID: 24316554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Case of Remnant Pancreatic Cancer after Pancreatoduodenectomy Successfully Treated Using Chemotherapy and Carbon-Ion Radiotherapy].
    Yamamoto T; Tokunou K; Yamamoto H; Kamei R; Kitamura Y; Ando S
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):1982-1984. PubMed ID: 28133196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].
    Gong JF; Zhang XD; Li J; Di LJ; Jin ML; Shen L
    Ai Zheng; 2007 Aug; 26(8):890-4. PubMed ID: 17697554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study on low dose gemcitabine plus oral chemotherapy with uracil-tegafur and cyclophosphamide in combination with radiotherapy against recurrent and advanced pancreatic cancer.
    Nio Y; Hashimoto K; Yano S; Itakura M; Koike M; Yamaguchi K; Endo S; Tsuji M; Higami T; Maruyama R
    Oncol Rep; 2005 Aug; 14(2):401-8. PubMed ID: 16012722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of advanced pancreatic cancer showing remarkable response to gemcitabine treatment].
    Masaki T; Ohkawa S; Hirokawa S; Miyakawa K; Tamai S; Tarao K
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1333-6. PubMed ID: 14518416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.